QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

MGTX

QT77MeiraGTx Holdings plc
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
11.32
+0.91+8.74%
OverviewShort InterestFilings
MGTXQT77MeiraGTx Holdings plc·NASDAQ
OverviewShort InterestFilings
11.32+8.74%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-2.04
Insider Own-
Shs Outstand-
Perf Week17.92%
Market Cap964.06MForward P/E-EPS next Y-1.54Insider Trans-Shs Float-Perf Month23.99%
Enterprise Value980.06MPEG-EPS next Q-0.31Inst Own-Short Float-Perf Quarter54.01%
Income-137282841.00P/S12.09EPS this Y20.89%Inst Trans-Short Ratio-Perf Half Y31.63%
Sales79.76MP/B-EPS next Y4.57%ROA-49.27%Short Interest-Perf YTD42.39%
Book/sh-P/C102.23EPS next 5Y-ROE474.91%52W High11.85 -4.47%Perf Year78.83%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-109.97%52W Low6.07 86.49%Perf 3Y-
Dividend Est.-EV/EBITDA-10.24Sales past 3/5Y71.71% 38.32%Gross Margin91.64%Volatility4.27% 3.89%Perf 5Y-
Dividend TTM-EV/Sales12.29EPS Y/Y TTM30.19%Oper. Margin-131.89%ATR (14)0.62Perf 10Y-
Dividend Ex-Date-Quick Ratio0.55Sales Y/Y TTM15.15%Profit Margin-151.12%RSI (14)69.04Recom2.00
Dividend Gr. 3/5Y-Current Ratio0.55EPS Q/Q-11.76%SMA2016.89%Beta1.88Target Price25.00
Payout0.00%Debt/Eq-1.51Sales Q/Q-100.00%SMA5016.75%Rel Volume2.84Prev Close10.41
Employees375LT Debt/Eq-10.17EarningsAug 13SMA20034.57%Avg Volume887.84KPrice11.32
IPO DateJun 08, 2018Option/ShortYes / YesEPS/Sales Surpr.-32.56% -100.00%Net Debt/EBITDA-0.17Volume2,519,631Change8.74%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-17-26ReiteratedRBC CapitalOutperform$16 → $24
Mar-27-26ReiteratedPiper SandlerOverweight$26
Nov-24-25InitiatedH.CBuy$20
Nov-14-25ReiteratedRBC CapitalOutperform$9.00 → $16
Aug-13-24ReiteratedRBC CapitalOutperform$9.00
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue388133
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A28524
Gross Profit11779
Selling, General and Administrative Excl. Other545354
Research and Development116130119
Other Operating Expense-201
Operating Income-158-106-164
Interest Expense121213
Unusual Expense
———
Non-Operating Income (Expense)-14-4-30
Net Income Before Taxes-157-114-148
Income Taxes
000
Consolidated Net Income-157-114-148
Net Income From Continuing Operations-157-114-148
Net Income-157-114-148
EPS (Recurring)-2.04-1.42-2.12
EPS (Basic, Before Extraordinaries)-2.04-1.42-2.12
EPS (Diluted)-2.04-1.42-2.12
EBITDA-133-89-122
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio24.137.85—
Gross Margin28.9595.0627.27
Operating Margin-415.79-130.86-496.97
Net Margin-413.16-140.74-448.48
Shares Outstanding818070
Market Capitalization917636—
Operating Lease Expense
———
Insider Trading Volume
$11.88$11.21$10.53$9.85$9.18● Close Price0.00K207.81K415.61K623.42K831.23KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Harris Keith R.DirectorJun 10 '26Option Exercise0.00150,0000200,000Jun 10 12:00 AM
Forbes AlexandriaPRESIDENT & CEOMay 19 '26Sale9.1762,000568,5401,387,695May 19 12:00 AM
Giroux RichardCFO & COOApr 21 '26Sale10.2256,000572,320971,530Apr 21 12:00 AM
Naylor StuartCHIEF DEV. OFFICERApr 07 '26Sale9.3627,661258,907668,505Apr 07 12:00 AM
Forbes AlexandriaPRESIDENT & CEOMar 24 '26Sale7.4162,000459,4201,449,695Mar 24 12:00 AM
Zeldin Robert KCHIEF MEDICAL OFFICERFeb 21 '26Option Exercise0.0015,0000175,840Feb 23 12:00 AM
Wollin Robert JGENERAL COUNSEL AND SECRETARYFeb 21 '26Option Exercise0.0022,500063,326Feb 23 12:00 AM
Naylor StuartCHIEF DEV. OFFICERFeb 21 '26Option Exercise0.0050,0000707,916Feb 23 12:00 AM
Giroux RichardCFO & COOFeb 21 '26Option Exercise0.00120,00001,059,256Feb 23 12:00 AM
Forbes AlexandriaPRESIDENT & CEOFeb 21 '26Option Exercise0.00125,00001,544,743Feb 23 12:00 AM
Zeldin Robert KCHIEF MEDICAL OFFICERJan 17 '26Option Exercise0.0070,0000182,291Jan 21 12:00 AM
Wollin Robert JGENERAL COUNSEL AND SECRETARYJan 17 '26Option Exercise0.00100,000079,282Jan 21 12:00 AM
Naylor StuartCHIEF DEV. OFFICERJan 17 '26Option Exercise0.00150,0000718,166Jan 21 12:00 AM
Giroux RichardCFO & COOJan 17 '26Option Exercise0.00620,00001,163,172Jan 21 12:00 AM
Forbes AlexandriaPRESIDENT & CEOJan 17 '26Option Exercise0.00620,00001,646,159Jan 21 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR